By The Registry Staff Another firm in the Bay Area is taking steps to exit its lease. Graphite Bio, a gene editing company, has opted to pay $58 million to terminate its lease at its South San Francisco headquarters, according to a report from The Real Deal. Graphite Bio had committed in January 2022 to […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
A regional owner-operator has acquired Mission Villa Senior Living, a 34-unit memory...
ByThe RegistryOctober 3, 2026Hines is moving its third generation into full command of the $91...
ByThe RegistryOctober 2, 2026Developer N17 has taken Menlo Park to court over the city's refusal...
ByThe RegistryOctober 2, 2026A legal demand from California Rural Legal Assistance and nine Valley groups,...
ByThe RegistryOctober 2, 2026